Scott Fidel
Stock Analyst at Stephens & Co.
(4.48)
# 550
Out of 4,667 analysts
173
Total ratings
68.75%
Success rate
12.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACS PACS Group | Maintains: Overweight | $48 → $31 | $17.28 | +79.40% | 4 | Nov 18, 2024 | |
| ADUS Addus HomeCare | Maintains: Overweight | $143 → $145 | $120.99 | +19.84% | 11 | Nov 6, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $410 | $322.69 | +27.06% | 12 | Nov 1, 2024 | |
| ENSG The Ensign Group | Maintains: Overweight | $163 → $167 | $144.73 | +15.39% | 9 | Oct 28, 2024 | |
| GRDN Guardian Pharmacy Services | Initiates: Overweight | $21 | $21.27 | -1.27% | 1 | Oct 22, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $632 → $605 | $599.03 | +1.00% | 21 | Oct 16, 2024 | |
| HUM Humana | Reiterates: Equal-Weight | $250 | $294.84 | -15.21% | 7 | Oct 9, 2024 | |
| PNTG The Pennant Group | Reiterates: Overweight | $40 | $30.78 | +29.95% | 17 | Oct 9, 2024 | |
| ARDT Ardent Health Partners | Reiterates: Overweight | $24 | $16.35 | +46.79% | 2 | Sep 19, 2024 | |
| ELV Elevance Health | Reiterates: Overweight | $615 | $399.15 | +54.08% | 3 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $98.93 | +6.14% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $78 | $59.10 | +31.98% | 8 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $320 | $294.64 | +8.61% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $200 | $197.52 | +1.26% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $7 | $11.95 | -41.42% | 3 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $95 → $122 | $149.79 | -18.55% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $39.10 | +135.29% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $280 | $324.56 | -13.73% | 9 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $95 | $16.31 | +482.46% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $103 | $89.96 | +14.50% | 12 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $5.77 | -74.00% | 3 | Nov 11, 2022 |
PACS Group
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $17.28
Upside: +79.40%
Addus HomeCare
Nov 6, 2024
Maintains: Overweight
Price Target: $143 → $145
Current: $120.99
Upside: +19.84%
The Cigna Group
Nov 1, 2024
Reiterates: Overweight
Price Target: $410
Current: $322.69
Upside: +27.06%
The Ensign Group
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $144.73
Upside: +15.39%
Guardian Pharmacy Services
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $21.27
Upside: -1.27%
UnitedHealth Group
Oct 16, 2024
Maintains: Overweight
Price Target: $632 → $605
Current: $599.03
Upside: +1.00%
Humana
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $294.84
Upside: -15.21%
The Pennant Group
Oct 9, 2024
Reiterates: Overweight
Price Target: $40
Current: $30.78
Upside: +29.95%
Ardent Health Partners
Sep 19, 2024
Reiterates: Overweight
Price Target: $24
Current: $16.35
Upside: +46.79%
Elevance Health
Sep 5, 2024
Reiterates: Overweight
Price Target: $615
Current: $399.15
Upside: +54.08%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $98.93
Upside: +6.14%
Aug 5, 2024
Reiterates: Equal-Weight
Price Target: $78
Current: $59.10
Upside: +31.98%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $320
Current: $294.64
Upside: +8.61%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $200
Current: $197.52
Upside: +1.26%
May 3, 2024
Maintains: Equal-Weight
Price Target: $6 → $7
Current: $11.95
Upside: -41.42%
May 1, 2024
Maintains: Equal-Weight
Price Target: $95 → $122
Current: $149.79
Upside: -18.55%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $39.10
Upside: +135.29%
Nov 10, 2023
Reiterates: Overweight
Price Target: $280
Current: $324.56
Upside: -13.73%
Jun 27, 2023
Reiterates: Overweight
Price Target: $95
Current: $16.31
Upside: +482.46%
May 4, 2023
Reiterates: Equal-Weight
Price Target: $103
Current: $89.96
Upside: +14.50%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $5.77
Upside: -74.00%